Annual Current Assets
$10.45 M
-$10.08 M-49.08%
December 31, 2023
Summary
- As of February 26, 2025, CLRB annual total current assets is $10.45 million, with the most recent change of -$10.08 million (-49.08%) on December 31, 2023.
- During the last 3 years, CLRB annual current assets has fallen by -$47.49 million (-81.96%).
- CLRB annual current assets is now -81.96% below its all-time high of $57.94 million, reached on December 31, 2020.
Performance
CLRB Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$35.90 M
+$7.99 M+28.65%
September 30, 2024
Summary
- As of February 26, 2025, CLRB quarterly total current assets is $35.90 million, with the most recent change of +$7.99 million (+28.65%) on September 30, 2024.
- Over the past year, CLRB quarterly current assets has stayed the same.
- CLRB quarterly current assets is now -38.04% below its all-time high of $57.94 million, reached on December 31, 2020.
Performance
CLRB Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
CLRB Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -49.1% | 0.0% |
| 3 y3 years | -82.0% | -13.3% |
| 5 y5 years | -25.1% | +143.3% |
CLRB Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -71.4% | at low | -13.2% | +540.0% |
| 5 y | 5-year | -82.0% | at low | -38.0% | +540.0% |
| alltime | all time | -82.0% | +716.8% | -38.0% | >+9999.0% |
Cellectar Biosciences Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $35.90 M(+28.6%) |
| Jun 2024 | - | $27.91 M(-32.5%) |
| Mar 2024 | - | $41.37 M(+295.7%) |
| Dec 2023 | $1.62 M(+53.0%) | $10.45 M(-48.0%) |
| Sep 2023 | - | $20.11 M(+258.5%) |
| Jun 2023 | - | $5.61 M(-59.5%) |
| Mar 2023 | - | $13.85 M(-32.6%) |
| Dec 2022 | $1.06 M(+68.2%) | $20.53 M(+9.4%) |
| Sep 2022 | - | $18.76 M(-25.8%) |
| Jun 2022 | - | $25.29 M(-19.5%) |
| Mar 2022 | - | $31.39 M(-14.2%) |
| Dec 2021 | $630.30 K(-12.4%) | $36.57 M(-11.6%) |
| Sep 2021 | - | $41.39 M(-12.2%) |
| Jun 2021 | - | $47.12 M(-13.4%) |
| Mar 2021 | - | $54.40 M(-6.1%) |
| Dec 2020 | $719.60 K(-16.8%) | $57.94 M(+192.6%) |
| Sep 2020 | - | $19.80 M(-14.1%) |
| Jun 2020 | - | $23.04 M(+193.1%) |
| Mar 2020 | - | $7.86 M(-30.9%) |
| Dec 2019 | $865.10 K(-21.5%) | $11.39 M(-22.8%) |
| Sep 2019 | - | $14.75 M(-18.9%) |
| Jun 2019 | - | $18.18 M(+63.9%) |
| Mar 2019 | - | $11.09 M(-20.5%) |
| Dec 2018 | $1.10 M(-54.0%) | $13.95 M(-18.5%) |
| Sep 2018 | - | $17.11 M(+241.2%) |
| Jun 2018 | - | $5.02 M(-34.4%) |
| Mar 2018 | - | $7.65 M(-27.0%) |
| Dec 2017 | $2.40 M(-23.4%) | $10.47 M(+56.6%) |
| Sep 2017 | - | $6.69 M(-28.4%) |
| Jun 2017 | - | $9.34 M(-23.4%) |
| Mar 2017 | - | $12.19 M(-0.1%) |
| Dec 2016 | $3.13 M(-8.3%) | $12.19 M(+98.6%) |
| Sep 2016 | - | $6.14 M(-24.6%) |
| Jun 2016 | - | $8.14 M(+262.6%) |
| Mar 2016 | - | $2.24 M(-46.3%) |
| Dec 2015 | $3.42 M(-8.2%) | $4.18 M(+40.6%) |
| Sep 2015 | - | $2.97 M(-40.6%) |
| Jun 2015 | - | $5.01 M(-31.0%) |
| Mar 2015 | - | $7.26 M(-25.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $3.72 M(-8.1%) | $9.70 M(-18.6%) |
| Sep 2014 | - | $11.92 M(+491.3%) |
| Jun 2014 | - | $2.02 M(-50.5%) |
| Mar 2014 | - | $4.08 M(+47.2%) |
| Dec 2013 | $4.05 M(-36.2%) | $2.77 M(-49.6%) |
| Sep 2013 | - | $5.49 M(-8.9%) |
| Jun 2013 | - | $6.03 M(-25.6%) |
| Mar 2013 | - | $8.11 M(+58.1%) |
| Dec 2012 | $6.35 M(+33.7%) | $5.13 M(-14.3%) |
| Sep 2012 | - | $5.99 M(-18.4%) |
| Jun 2012 | - | $7.34 M(+82.3%) |
| Mar 2012 | - | $4.03 M(-30.8%) |
| Dec 2011 | $4.75 M(+34.8%) | $5.82 M(+175.8%) |
| Sep 2011 | - | $2.11 M(-39.4%) |
| Jun 2011 | - | $3.48 M(+219.9%) |
| Mar 2011 | - | $1.09 M(-15.0%) |
| Dec 2010 | $3.52 M(+5830.0%) | $1.28 M(-63.1%) |
| Sep 2010 | - | $3.47 M(-0.3%) |
| Jun 2010 | - | $3.47 M(-39.7%) |
| Mar 2010 | - | $5.76 M(-35.1%) |
| Dec 2009 | $59.40 K(-19.5%) | $8.87 M(+49.7%) |
| Sep 2009 | - | $5.93 M(+29.4%) |
| Jun 2009 | - | $4.58 M(-35.2%) |
| Mar 2009 | - | $7.06 M(+407.3%) |
| Dec 2008 | $73.80 K(+53.1%) | $1.39 M(-68.4%) |
| Sep 2008 | - | $4.40 M(-22.8%) |
| Jun 2008 | - | $5.70 M(-14.4%) |
| Mar 2008 | - | $6.66 M(-39.8%) |
| Dec 2007 | $48.20 K(+38.9%) | $11.06 M(-29.2%) |
| Sep 2007 | - | $15.62 M(-23.8%) |
| Jun 2007 | - | $20.50 M(+113.5%) |
| Mar 2007 | - | $9.60 M(-19.3%) |
| Dec 2006 | $34.70 K(-74.6%) | $11.89 M(-16.8%) |
| Sep 2006 | - | $14.29 M(-13.7%) |
| Jun 2006 | - | $16.57 M(-7.0%) |
| Mar 2006 | - | $17.82 M(+271.1%) |
| Dec 2005 | $136.80 K | $4.80 M(-15.1%) |
| Sep 2005 | - | $5.66 M(+182.1%) |
| Jun 2005 | - | $2.01 M(>+9900.0%) |
| Mar 2005 | - | $100.00 |
FAQ
- What is Cellectar Biosciences annual total current assets?
- What is the all time high annual current assets for Cellectar Biosciences?
- What is Cellectar Biosciences annual current assets year-on-year change?
- What is Cellectar Biosciences quarterly total current assets?
- What is the all time high quarterly current assets for Cellectar Biosciences?
- What is Cellectar Biosciences quarterly current assets year-on-year change?
What is Cellectar Biosciences annual total current assets?
The current annual current assets of CLRB is $10.45 M
What is the all time high annual current assets for Cellectar Biosciences?
Cellectar Biosciences all-time high annual total current assets is $57.94 M
What is Cellectar Biosciences annual current assets year-on-year change?
Over the past year, CLRB annual total current assets has changed by -$10.08 M (-49.08%)
What is Cellectar Biosciences quarterly total current assets?
The current quarterly current assets of CLRB is $35.90 M
What is the all time high quarterly current assets for Cellectar Biosciences?
Cellectar Biosciences all-time high quarterly total current assets is $57.94 M
What is Cellectar Biosciences quarterly current assets year-on-year change?
Over the past year, CLRB quarterly total current assets has changed by $0.00 (0.00%)